Navigation Links
U.S. Physicians Report Diabetic Nephropathy as the Renal Condition with the Highest Unmet Need for Treatment
Date:3/14/2013

EXTON, Pa., March 14, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that nephrologists believe that diabetic nephropathy is the renal condition with the highest unmet need for treatment, followed closely by acute kidney injury and polycystic kidney disease, according to TreatmentTrends: Diabetic Nephropathy (U.S.), a study of 105 U.S. physicians (52 nephrologists, 26 endocrinologists and 27 primary care physicians).

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36805LOGO )

For all physician groups, angiotensin-converting-enzyme inhibitors (ACEIs) are the most prescribed class of drugs for diabetic nephropathy followed by angiotensin-receptor blockers (ARBs) and diuretics, while renin inhibitors are used the least. All physician groups use lisinopril, such as Merck's Prinvil or AstraZeneca's Zestril, more often than other ACE inhibitors. Endocrinologists prescribe ramipril, such as Pfizer's Altace or Sanofi's Triatec, significantly more often than nephrologists and primary care physicians do.

"Now that bardoxolone is no longer in development, the focus is on many new clinical compounds in development for diabetic nephropathy, including CTP-499 from Concert Pharmaceuticals or CCX140 from ChemoCentryx among others," said Rob Dubman , BioTrends' Director of Nephrology. "However, this study indicates that nephrologists are divided regarding the ideal primary end point for a product in clinical development, such as risk of doubling serum creatinine, change in creatinine clearance rate, or GFR, leading to greater complexity for the manufacturers."

TreatmentTrends®: Diabetic Nephropathy (U.S.) is a syndicated report, in which 105 U.S. physicians (52 nephrologists, 26 endocrinologists, and 27 primary care physicians) participated in an online survey. The intention of this study is to understand the diabetic nephropathy patient population, including patient load by stage and to understand what risk factors influence disease progression. In addition, this study covers the diagnosis and standard of care for patients with diabetic nephropathy and how therapy decisions differ based on disease presentation and specialty of physician treating. Finally, to understand the satisfaction with current treatment, potential for new pipeline products, and the unmet needs in the management of diabetic nephropathy.

About BioTrends Research GroupBioTrends Research Group provides syndicated and custom primary market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets. For information on BioTrends publications and research capabilities, please contact us at www.bio-trends.com.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks of their respective holders.For more information, contact:BioTrends Research Group Decision Resources GroupRob Dubman

Christopher Comfort781-993-2592

781-993-2597 rdubman@bio-trends.comccomfort@dresources.com


'/>"/>
SOURCE BioTrends Research Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. American Academy of Family Physicians Foundation Launches Cities for Life
2. CentraState and Freehold Radiology Group train physicians from China
3. New Published Guidelines to Help Physicians Diagnose and Treat Lupus Kidney Disease
4. Ameritox Announces Educational Resources to Help Physicians Navigate Complex Compliance Issues
5. "AWAKEN" Survey Finds Only 50 Percent of Americans Understand Significant Health Impact of Narcolepsy, and Many Physicians Not Comfortable Diagnosing the Sleep Disorder
6. Physicians Practice Recognized for Print and Digital Excellence
7. HealthWarehouse.com and Northwest Physicians Network Partner to Provide Exclusive Discount Pharmacy Services to Patients
8. The American Society of Interventional Pain Physicians Announces Guidelines for Responsible Prescribing of Pain-Killers for Chronic Non-Cancer Pain
9. Homecare Community Dismayed that Medicare Will Start Prior Authorization for Wheelchairs without a Clinical Template for Physicians to Document Need
10. Physicians Find Medical Billers and Coders Within 48 Hours of Posting Jobs with MBC
11. Physicians Capital Investments, Physicians Capital Markets, and EDGE Realty Capital Markets announce a new strategic initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... 12, 2017 West Pharmaceutical Services, Inc. ... for injectable drug administration, today announced that it will ... on Thursday, October 26, 2017, and will follow with ... expectations at 9:00 a.m. Eastern Time. To participate on ... The conference ID is 94093362. ...
(Date:10/10/2017)... 2017  NDS received FDA 510(k) clearance in May 2017 for ... stand specifically designed for endoscopy environments. An innovative secondary monitor solution, ... solution to support the improvement of patient outcomes, procedural efficiency, and ... ... ...
(Date:10/4/2017)... to the Centers for Disease Control and Prevention (CDC), influenza vaccination ... is helping communities across Massachusetts , Connecticut ... flu shots through the end of the month. *Some exclusions ... ... shot is by the end of October, according to the Centers for ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance Group, ... Dallas, Miami, and Raleigh regions, is organizing an extended charity drive to benefit ... deadly chromosome abnormality. , After struggling since birth with several health challenges, T.J. ...
(Date:10/13/2017)... LEXINGTON, Ky. (PRWEB) , ... October 13, 2017 , ... ... MD, MPH to become its next President and Chief Executive Officer, succeeding Dr. James ... and CEO Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps ... provides a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... New York, NY (PRWEB) , ... October 13, 2017 , ... ... most influential people in business to advocate for action towards gender equality at their ... 18,000 views from around the globe, and reached a social audience of over 3 ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
Breaking Medicine News(10 mins):